Date: Thursday 17 September, 10-11am
Venue: Online webinar
Register: Here
Co-hosted with One Nucleus, this webinar will focus on the key considerations for transitioning small molecules from preclinical through clinical development. Experts will discuss the technological aspects of drug development and describe practical approaches to improve bioavailability of poorly soluble drugs.
In addition, the speakers will discuss the ways physiologically-based pharmacokinetic (PBPK) models are used to predict the pharmacokinetics (PK) of drugs in various human populations to support clinical trial design. A review of key regulatory and guideline requirements for early clinical research will also be presented.
Date:
Thursday, 17 September, 2020 - 10:00 to 11:00
